Abstract:In vivo monitoring of cargo protein delivery is critical for understanding the pharmacological efficacies and mechanisms during cancer therapy, but it still remains a formidable challenge because of the difficulty in observing nonfluorescent proteins at high resolution and sensitivity. Here we report an outer-frame-degradable nanovehicle featuring near-infrared (NIR) dual luminescence for real-time tracking of protein delivery in vivo. Upconversion nanoparticles (UCNPs) and fluorophore-doped degradable macroporous silica (DS) with spectral overlap were coupled to form a core-shell nanostructure as a therapeutic protein nanocarrier, which was eventually enveloped with a hyaluronic acid (HA) shell to prevent protein leakage and for recognizing tumor sites. The DS layer served as both a container to accommodate the therapeutic proteins and a filter to attenuate upconversion luminescence (UCL) of the inner UCNPs. After the nanovehicles selectively accumulated at tumor sites and entered cancer cells, intracellular hyaluronidase (HAase) digested the outermost HA protective shell and initiated the outer frame degradation-induced protein release and UCL restoration of UCNPs in the intracellular environment. Significantly, the biodistribution of the nanovehicles can be traced at the 710 nm NIR fluorescence channel of DS, whereas the protein release can be monitored at the 660 nm NIR fluorescence channel of UCNPs. Real-time tracking of protein delivery and release was achieved in vitro and in vivo by NIR fluorescence imaging. Moreover, in vitro and in vivo studies manifest that the protein cytochrome c-loaded nanovehicles exhibited excellent cancer therapeutic efficacy. This nanoplatform assembled by the outer-frame-degradable nanovehicles featuring NIR dual luminescence not only advances our understanding of where, when, and how therapeutic proteins take effect in vivo but also provides a universal route for visualizing the translocation of other bioactive macromolecules in cancer treatment and intervention.

One-Step Synthesis of Ribonucleases A–Ag Nanocomposites As Fluorescent Nanodrugs for in Vivo Delivery

Synthesis of Protein Nano-Conjugates for Cancer Therapy

One-pot synthesis of aptamer-functionalized silver nanoclusters for cell-type-specific imaging.

Programmable Assembly of Multivalent DNA‐Protein Superstructures for Tumor Imaging and Targeted Therapy

Outer-Frame-Degradable Nanovehicles Featuring Near-Infrared Dual Luminescence for in Vivo Tracking of Protein Delivery in Cancer Therapy

Fluoropolymer Coated DNA Nanoclews for Volumetric Visualization of Oligonucleotides Delivery and Near Infrared Light Activated Anti‐Angiogenic Oncotherapy

Biodegradable Nanosyringes for Intracellular Amplification-Based Dual-Diagnosis and Gene Therapy in Single Living Cells

Assembly-Enhanced Indocyanine Green Nanoparticles for Fluorescence Imaging-Guided Photothermal Therapy

Prolonged near-infrared fluorescence imaging of microRNAs and proteases in vivo by aggregation-enhanced emission from DNA-AuNCs Nanomachines

Nanoplex Delivery of Sirna and Prodrug Enzyme for Multimodality Image-Guided Molecular Pathway Targeted Cancer Therapy.

Prolonged Near-Infrared Fluorescence Imaging of Micrornas and Proteases in Vivo by Aggregation-Enhanced Emission from DNA-AuNC Nanomachines.

Combinational Application of Metal–organic Frameworks‐based Nanozyme and Nucleic Acid Delivery in Cancer Therapy

Redox-Responsive Molecularly Imprinted Nanoparticles for Targeted Intracellular Delivery of Protein Toward Cancer Therapy.

Fluorescent Protein-Based Multi-Functional Nanoparticles for Bioimaging and Drug Delivery

Simultaneous nuclear imaging and intranuclear drug delivery by nuclear-targeted multifunctional upconversion nanoprobes.

Nir-Activated Spatiotemporally Controllable Nanoagent For Achieving Synergistic Gene-Chemo-Photothermal Therapy In Tumor Ablation

Aggregation Induced Emission Fluorogens Based Nanotheranostics for Targeted and Imaging-Guided Chemo-Photothermal Combination Therapy

Plant Protein-Directed Synthesis of Luminescent Gold Nanocluster Hybrids for Tumor Imaging

Targeted Intracellular Controlled Drug Delivery and Tumor Therapy through in Situ Forming Ag Nanogates on Mesoporous Silica Nanocontainers.

Engineered Near‐Infrared Fluorescent Protein Assemblies for Robust Bioimaging and Therapeutic Applications

Intelligent Nanoprobe: Acid-Responsive Drug Release and In Situ Evaluation of Its Own Therapeutic Effect